- Home
- IVA vs PFL Comparison
IVA vs PFL Comparison
Compare IVA & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- PFL
- Stock Information
- Founded
- IVA 2011
- PFL 2003
- Country
- IVA France
- PFL United States
- Employees
- IVA N/A
- PFL N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- IVA Health Care
- PFL Finance
- Exchange
- IVA Nasdaq
- PFL Nasdaq
- Market Cap
- IVA 359.6M
- PFL 374.5M
- IPO Year
- IVA 2020
- PFL N/A
- Fundamental
- Price
- IVA $4.36
- PFL $8.46
- Analyst Decision
- IVA Strong Buy
- PFL
- Analyst Count
- IVA 4
- PFL 0
- Target Price
- IVA $10.50
- PFL N/A
- AVG Volume (30 Days)
- IVA 29.2K
- PFL 113.7K
- Earning Date
- IVA 09-24-2025
- PFL 01-01-0001
- Dividend Yield
- IVA N/A
- PFL 11.53%
- EPS Growth
- IVA N/A
- PFL N/A
- EPS
- IVA N/A
- PFL N/A
- Revenue
- IVA $14,591,573.00
- PFL N/A
- Revenue This Year
- IVA $44.22
- PFL N/A
- Revenue Next Year
- IVA $24.23
- PFL N/A
- P/E Ratio
- IVA N/A
- PFL N/A
- Revenue Growth
- IVA N/A
- PFL N/A
- 52 Week Low
- IVA $1.53
- PFL $6.98
- 52 Week High
- IVA $4.36
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- IVA 74.37
- PFL 56.74
- Support Level
- IVA $3.44
- PFL $8.41
- Resistance Level
- IVA $3.58
- PFL $8.50
- Average True Range (ATR)
- IVA 0.30
- PFL 0.05
- MACD
- IVA 0.11
- PFL -0.00
- Stochastic Oscillator
- IVA 100.00
- PFL 53.57
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.